Professor, Yonsei University, South Korea
Professor Hyungil Jung has completed his Ph.D. from Cornell University and his postdoctoral from California Institute of Technology (Caltech). Since then he had received various awards in biotechnology field such as “Outstanding Contributions”, “Best Contribution Award”, “Excellence in Research Award”, “The 31st Industry-academic Cooperation Award”, “Best technology Award”, “Best Teaching Award” and many more because of his outstanding research ability in biotechnology field.
Transdermal drug delivery is regarded as an important route with high potential for drug delivery to overcome limitations of oral delivery and hypodermic injections. Among various delivery methods available, microneedles have gained interest due to their ability in delivering drugs with a high efficacy compared with topical application. Microneedles are referred to microscopic needles that are capable of delivering pharmaceutical compounds, proteins and even cosmetics into the skin in a minimally invasive manner. Especially, dissolving microneedle patches contain micron scale dissolvable needles that are capable of delivering encapsu¬lated compounds into the skin without causing any pain. Therefore, dissolving microneedles are expected to replace the current hypodermic injections in near future. Beside cosmetics and beauty dissolving microneedle patches that are already in the market, we have developed insulin microneedle patches that are capable of delivering the required dosage of insulin to mouse and are currently improving this system for clinical trial tests. We are continuously working on developing limitations of microneedle based delivery system and that makes them as one of the fastest growing dissolving microneedle research groups in the world with various novel researches in this field.